These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8702612)

  • 1. Identification of the alpha chain lysine donor sites involved in factor XIIIa fibrin cross-linking.
    Sobel JH; Gawinowicz MA
    J Biol Chem; 1996 Aug; 271(32):19288-97. PubMed ID: 8702612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-Chain cross-linking in fibrin(ogen) Marburg.
    Sobel JH; Trakht I; Wu HQ; Rudchenko S; Egbring R
    Blood; 1995 Aug; 86(3):989-1000. PubMed ID: 7620190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen).
    Ritchie H; Lawrie LC; Crombie PW; Mosesson MW; Booth NA
    J Biol Chem; 2000 Aug; 275(32):24915-20. PubMed ID: 10816585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of respective lysine donor and glutamine acceptor sites involved in factor XIIIa-catalyzed fibrin α chain cross-linking.
    Wang W
    J Biol Chem; 2011 Dec; 286(52):44952-64. PubMed ID: 22030394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact with the N termini in the central E domain enhances the reactivities of the distal D domains of fibrin to factor XIIIa.
    Samokhin GP; Lorand L
    J Biol Chem; 1995 Sep; 270(37):21827-32. PubMed ID: 7665605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical characterization of crosslinked derivatives isolated from alpha chain oligomers formed during early stages of fibrin crosslinking.
    Sobel JH; Thibodeau CA; Gawinowicz Kolks MA; Canfield RE
    Thromb Haemost; 1988 Oct; 60(2):160-9. PubMed ID: 3217917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation factor XIIIa undergoes a conformational change evoked by glutamine substrate. Studies on kinetics of inhibition and binding of XIIIA by a cross-reacting antifibrinogen antibody.
    Mitkevich OV; Shainoff JR; DiBello PM; Yee VC; Teller DC; Smejkal GB; Bishop PD; Kolotushkina IS; Fickenscher K; Samokhin GP
    J Biol Chem; 1998 Jun; 273(23):14387-91. PubMed ID: 9603949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of factor XIIIA-reactive glutamine acceptor and lysine donor sites within fibronectin-binding protein (FnbA) from Staphylococcus aureus.
    Anderson ET; Fletcher L; Severin A; Murphy E; Baker SM; Matsuka YV
    Biochemistry; 2004 Sep; 43(37):11842-52. PubMed ID: 15362870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.
    Kimura S; Aoki N
    J Biol Chem; 1986 Nov; 261(33):15591-5. PubMed ID: 2877981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen.
    Matsuka YV; Medved LV; Migliorini MM; Ingham KC
    Biochemistry; 1996 May; 35(18):5810-6. PubMed ID: 8639541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody directed to a fibrinogen A alpha #529-539 epitope inhibits alpha-chain crosslinking by transglutaminases.
    Mitkevich OV; Sobel JH; Shainoff JR; Vlasik TN; Kalantarov GF; Trakht IN; Streltsova ZA; Samokhin GP
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):85-92. PubMed ID: 8845468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites.
    Achyuthan KE; Slaughter TF; Santiago MA; Enghild JJ; Greenberg CS
    J Biol Chem; 1993 Oct; 268(28):21284-92. PubMed ID: 8104938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor.
    Tamaki T; Aoki N
    J Biol Chem; 1982 Dec; 257(24):14767-72. PubMed ID: 6129243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of alpha-polymer from in vitro and in vivo highly cross-linked human fibrin.
    Fretto LJ; McKee PA
    J Biol Chem; 1978 Sep; 253(18):6614-22. PubMed ID: 150419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and partial structural characterization of an equine fibrinogen CNBr fragment that exhibits immunologic cross-reactivity with an A alpha-chain cross-linking region of human fibrinogen.
    Sobel JH; Thibodeau CA; Kolks MA; Canfield RE
    Biochemistry; 1990 Sep; 29(38):8907-16. PubMed ID: 2271566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa.
    Schense JC; Hubbell JA
    Bioconjug Chem; 1999; 10(1):75-81. PubMed ID: 9893967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Position of gamma-chain carboxy-terminal regions in fibrinogen/fibrin cross-linking mixtures.
    Siebenlist KR; Meh DA; Mosesson MW
    Biochemistry; 2000 Nov; 39(46):14171-5. PubMed ID: 11087365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking.
    Shainoff JR; Urbanic DA; DiBello PM
    J Biol Chem; 1991 Apr; 266(10):6429-37. PubMed ID: 1672529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.
    Mosesson MW; Siebenlist KR; Hainfeld JF; Wall JS
    J Struct Biol; 1995; 115(1):88-101. PubMed ID: 7577232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.